{"id":11709,"date":"2022-03-18T12:00:00","date_gmt":"2022-03-18T11:00:00","guid":{"rendered":"https:\/\/xd3kj9bvqee.preview.infomaniak.website\/?p=11709"},"modified":"2022-03-17T23:44:31","modified_gmt":"2022-03-17T22:44:31","slug":"anjac-health-beauty-strengthens-in-north-america-and-its-pharmaceutical-activities","status":"publish","type":"post","link":"https:\/\/www.industries-cosmetiques.fr\/en\/anjac-health-beauty-strengthens-in-north-america-and-its-pharmaceutical-activities\/","title":{"rendered":"Anjac Health & Beauty strengthens its position in North America and its pharmaceutical activities"},"content":{"rendered":"

Anjac Health & Beauty (Anjac) has announced the acquisition of Pillar5 Pharma (Pillar5), a leading CDMO specialized in the production of sterile ophthalmic solutions and niche solid forms (tablets, capsules, etc.). This operation confirms Anjac's international expansion and extends its healthcare offering with a new ophthalmic range to serve local and international brands and laboratories. This is Anjac's second major operation in 2022, following the merger with Apollo Healthcare last January.<\/p>\n\n\n\n

Pillar5, CDMO a key player in the sterile ophthalmology market in North America.<\/p>

Advertising<\/div>
\"site-industries-cosmetiques<\/a><\/div><\/div>\n\n\n\n

A Canadian company, Pillar5 is one of North America's leading CDMOs for the production of sterile ophthalmic solutions and solid forms (tablets, capsules, etc.) Pillar5 is a pioneer and the only CDMO to offer innovative ophthalmic solutions on the North American market, namely preservative-free sterile multidoses.<\/p>\n\n\n\n

An independent company since 2009, Pillar5, based in Arnprior, Ontario, offers a complete range of services, from product formulation and manufacture to packaging customization and technical services. With a diversified and loyal customer portfolio, Pillar5 supports major pharmaceutical companies as well as ophthalmic care specialists.<\/p>\n\n\n\n

The company has 150 employees and sales of $CAD 50 million.<\/p>\n\n\n\n

A unique entrepreneurial dynamism<\/h2>\n\n\n\n

With Pillar5, the Anjac group signs its 9\u1d49 acquisition in five years, and sees its overall sales reach almost 650 million euros following this operation, doubling in the space of three years. Each new acquisition represents an opportunity for the Anjac Group to extend its range of services in specific fields, while leveraging their complementarities. The Anjac Group now comprises 14 expert companies, with 22 R&D and manufacturing sites.<\/p>\n\n\n\n

\"We are delighted with this strategic acquisition, which will enable us to expand into a key new segment, the ophthalmic market, and more specifically into the high value-added innovation of preservative-free, multi-dose sterile ophthalmic solutions.<\/em>explains Aur\u00e9lien Chaufour, President of the Anjac Group.<\/p>\n\n\n\n

\"We are delighted to be joining a family-owned industrial group that will support us in our ambitious expansion plans. We have already identified synergies, notably with international customers who can be supported by Pillar5 and other companies in the Anjac group\".<\/em>says Dwight Gorham, President and CEO of Pillar5.<\/p>","protected":false},"excerpt":{"rendered":"

Anjac Health & Beauty (Anjac) a annonc\u00e9 l\u2019acquisition de Pillar5 Pharma (Pillar5), l\u2019un des principaux fa\u00e7onniers (CDMO) sp\u00e9cialis\u00e9s dans la production de solutions ophtalmiques st\u00e9riles et de formes solides (comprim\u00e9s, capsules, etc.) de niches. Cette op\u00e9ration confirme l\u2019expansion internationale d\u2019Anjac et \u00e9tend son offre sant\u00e9 avec une nouvelle offre ophtalmique pour servir les marques et […]<\/p>\n","protected":false},"author":148,"featured_media":11710,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"external_url":"","footnotes":""},"categories":[56],"tags":[61],"class_list":{"0":"post-11709","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-management","8":"tag-info-marche"},"acf":{"nc":"Nicolas.Fuseau@grayling.com","nc2":"","nc3":"","nc4":"","nc5":"","nom_url":"","lien_url":""},"_links":{"self":[{"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/posts\/11709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/users\/148"}],"replies":[{"embeddable":true,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/comments?post=11709"}],"version-history":[{"count":0,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/posts\/11709\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/media\/11710"}],"wp:attachment":[{"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/media?parent=11709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/categories?post=11709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.industries-cosmetiques.fr\/en\/wp-json\/wp\/v2\/tags?post=11709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}